MitoChem Therapeutics, Inc.
PrivateLast Round
Grant
Sep 21, 2023
Total Funding Raised
$2.63M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
MitoChem Therapeutics, Inc. is a biotechnology company that develops small molecule therapeutics targeting mitochondrial dysfunction to treat neurodegenerative and retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoChem Therapeutics, Inc. Comparables
Compare MitoChem Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mitochon Pharmaceuticals | 86% | |
| NRG Therapeutics | 83% | |
| Evvia Therapeutics | 81% | |
MitoChem Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 21, 2023 | ||||
| Seed | Aug 11, 2022 |
MitoChem Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SC Launch | Grant, Seed |
| Foundation Fighting Blindness | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 133% MoM, reaching 1.5K.
- May 4, 2025
Monthly visitors grew 1008% MoM, from 89 to 986.
MitoChem Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoChem Therapeutics, Inc.'s valuation, stock price, and market status.